SCHEMBL23802602

SCHEMBL23802602

CC(C)=CCC/C(C)=C/CC/C(C)=C\CC/C(C)=C/COS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.56
ALDH1A1 P00352 1/20 0.44
ALOX15 P16050 1/20 0.44
FNTA P49354 2/20 0.44
FNTB P49356 2/20 0.44
PGGT1B P53609 1/20 0.44
DHODH Q02127 1/20 0.43
PGR P06401 1/20 0.42
HTR1A P08908 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
MAPT P10636 1/20 0.42
PTGS1 P23219 1/20 0.42
PDE4A P27815 1/20 0.42
MAPK1 P28482 1/20 0.42
DRD3 P35462 1/20 0.42
SNCA P37840 1/20 0.42
PDE3A Q14432 1/20 0.42
KMT2A Q03164 1/20 0.42
PTPN1 P18031 1/20 0.42
BACE1 P56817 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15246442 1.00 TRPV1 (0.56) TRPV1ALDH1A1ALOX15FNTAFNTB
SCHEMBL27733182 1.00 TRPV1 (0.56) TRPV1ALDH1A1ALOX15FNTAFNTB
SCHEMBL8058501 1.00 TRPV1 (0.56) TRPV1ALDH1A1ALOX15FNTAFNTB
SCHEMBL8058497 1.00 TRPV1 (0.56) TRPV1ALDH1A1ALOX15FNTAFNTB
SCHEMBL8622204 0.99 TRPV1 (0.58) TRPV1ALDH1A1ALOX15FNTAFNTB
SCHEMBL3092862 0.99 TRPV1 (0.58) TRPV1ALDH1A1ALOX15FNTAFNTB
SCHEMBL9417659 0.89 TRPV1 (0.50) TRPV1ALDH1A1FNTAFNTBDHODH
SCHEMBL9417658 0.89 TRPV1 (0.50) TRPV1ALDH1A1FNTAFNTBDHODH
SCHEMBL15246439 0.88 TRPV1 (0.52) TRPV1ALDH1A1ALOX15FNTAFNTB
SCHEMBL30218692 0.88 TRPV1 (0.52) TRPV1ALDH1A1ALOX15FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12146177-B2 Methods of making and using E,Z,E-geranylgeranyl diphosphate WISYS TECHNOLOGY FOUNDATION, INC. (US) 2024-11-19 US claimed
US-12146177-B2 Methods of making and using E,Z,E-geranylgeranyl diphosphate WISYS TECHNOLOGY FOUNDATION, INC. (US) 2024-11-19 US disclosed
US-20210285016-A1 METHODS OF MAKING AND USING E,Z,E-GERANYLGERANYL DIPHOSPHATE WISYS TECHNOLOGY FOUNDATION, INC. 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210285016-A1 METHODS OF MAKING AND USING E,Z,E-GERANYLGERANYL DIPHOSPHATE GGPS1, COASY, FDPS TRPV1 4825/4885ALDH1A1 2411/4885ALOX15 452/4885
US-12146177-B2 Methods of making and using E,Z,E-geranylgeranyl diphosphate GGPS1, COASY, FDPS TRPV1 4825/4885ALDH1A1 2411/4885ALOX15 452/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.